214 related articles for article (PubMed ID: 21816138)
21. Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: effect of diabetes in type 1 and type 2 diabetic rat models.
Coppey LJ; Gellett JS; Yorek MA
Endothelium; 2003; 10(2):89-94. PubMed ID: 12791516
[TBL] [Abstract][Full Text] [Related]
22. Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Yorek MA
J Diabetes Res; 2018; 2018():2967127. PubMed ID: 30057911
[TBL] [Abstract][Full Text] [Related]
23. Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril.
Davidson EP; Coppey LJ; Shevalye H; Obrosov A; Kardon RH; Yorek MA
Cornea; 2017 Jun; 36(6):725-731. PubMed ID: 28476051
[TBL] [Abstract][Full Text] [Related]
24. Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model.
Coppey L; Davidson E; Shevalye H; Obrosov A; Yorek M
J Diabetes Res; 2019; 2019():5020465. PubMed ID: 31485451
[TBL] [Abstract][Full Text] [Related]
25. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
[TBL] [Abstract][Full Text] [Related]
26. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
Coppey LJ; Davidson EP; Rinehart TW; Gellett JS; Oltman CL; Lund DD; Yorek MA
Diabetes; 2006 Feb; 55(2):341-8. PubMed ID: 16443766
[TBL] [Abstract][Full Text] [Related]
27. Insulin Treatment Attenuates Small Nerve Fiber Damage in Rat Model of Type 2 Diabetes.
Andreasen LJ; Kirk RK; Fledelius C; Yorek MA; Lykkesfeldt J; Akerstrom T
J Diabetes Res; 2020; 2020():9626398. PubMed ID: 32832565
[TBL] [Abstract][Full Text] [Related]
28. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
[TBL] [Abstract][Full Text] [Related]
29. Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice.
Coppey L; Lu B; Gerard C; Yorek MA
J Obes; 2012; 2012():326806. PubMed ID: 23056927
[TBL] [Abstract][Full Text] [Related]
30. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function.
Yorek MA; Coppey LJ; Gellett JS; Davidson EP; Bing X; Lund DD; Dillon JS
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1067-75. PubMed ID: 12376336
[TBL] [Abstract][Full Text] [Related]
31. Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model.
Fink B; Coppey L; Davidson E; Shevalye H; Obrosov A; Chheda PR; Kerns R; Sivitz W; Yorek M
Free Radic Res; 2020 May; 54(5):311-318. PubMed ID: 32326763
[TBL] [Abstract][Full Text] [Related]
32. Insulin therapy improves islet functions by restoring pancreatic vasculature in high-fat diet-fed streptozotocin-diabetic rats.
Gu H; Xia X; Chen Z; Liang H; Yan J; Xu F; Weng J
J Diabetes; 2014 May; 6(3):228-36. PubMed ID: 24812692
[TBL] [Abstract][Full Text] [Related]
33. Effect of tempol on peripheral neuropathy in diet-induced obese and high-fat fed/low-dose streptozotocin-treated C57Bl6/J mice.
Obrosov A; Shevalye H; Coppey LJ; Yorek MA
Free Radic Res; 2017 Apr; 51(4):360-367. PubMed ID: 28376643
[TBL] [Abstract][Full Text] [Related]
34. Determination of peripheral neuropathy in high-fat diet fed low-dose streptozotocin-treated female C57Bl/6J mice and Sprague-Dawley rats.
Coppey LJ; Shevalye H; Obrosov A; Davidson EP; Yorek MA
J Diabetes Investig; 2018 Sep; 9(5):1033-1040. PubMed ID: 29412513
[TBL] [Abstract][Full Text] [Related]
35. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats.
Jin HY; Lee KA; Song SK; Liu WJ; Choi JH; Song CH; Baek HS; Park TS
Eur J Pharmacol; 2012 Jan; 674(2-3):217-26. PubMed ID: 21641343
[TBL] [Abstract][Full Text] [Related]
36. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.
Terata K; Coppey LJ; Davidson EP; Dunlap JA; Gutterman DD; Yorek MA
Br J Pharmacol; 1999 Oct; 128(3):837-43. PubMed ID: 10516670
[TBL] [Abstract][Full Text] [Related]
37. Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.
Cotter MA; Jack AM; Cameron NE
Clin Sci (Lond); 2002 Sep; 103(3):311-21. PubMed ID: 12193157
[TBL] [Abstract][Full Text] [Related]
38. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
39. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
Velkoska E; Warner FJ; Cole TJ; Smith I; Morris MJ
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):49-55. PubMed ID: 19361967
[TBL] [Abstract][Full Text] [Related]
40. Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats.
Davidson EP; Coppey LJ; Kardon RH; Yorek MA
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1222-30. PubMed ID: 24519423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
